Document is current

Any future updates will be listed below

RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids

Crossref DOI link: https://doi.org/10.1007/s00280-025-04800-w

Published Online: 2025-09-12

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark